Postma MJ - Search Results

1

Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data.

de Vries R, van Bergen JE, de Jong-van den Berg LT, Postma MJ; PILOT-CT Study Group. de Vries R, et al. Among authors: postma mj. Value Health. 2006 Jan-Feb;9(1):1-11. doi: 10.1111/j.1524-4733.2006.00075.x. Value Health. 2006. PMID: 16441519 Free article.

2

[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment].

Postma MJ, Welte R, van den Hoek JA, Jager JC, van Doornum GJ, Coutinho RA. Postma MJ, et al. Ned Tijdschr Geneeskd. 1999 Nov 20;143(47):2383-5. Ned Tijdschr Geneeskd. 1999. PMID: 10590778 Dutch.

3

[Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam].

Postma MJ, van den Hoek JA, Beck EJ, Heeg B, Jager JC, Coutinho RA. Postma MJ, et al. Ned Tijdschr Geneeskd. 2000 Apr 15;144(16):749-54. Ned Tijdschr Geneeskd. 2000. PMID: 10812443 Dutch.

4

Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach.

Welte R, Kretzschmar M, Leidl R, van den Hoek A, Jager JC, Postma MJ. Welte R, et al. Among authors: postma mj. Sex Transm Dis. 2000 Oct;27(9):518-29. doi: 10.1097/00007435-200010000-00005. Sex Transm Dis. 2000. PMID: 11034526

5

Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Postma MJ, Baltussen RM, Heijnen ML, de Berg LT, Jager JC. Postma MJ, et al. Drugs Aging. 2000 Sep;17(3):217-27. doi: 10.2165/00002512-200017030-00005. Drugs Aging. 2000. PMID: 11043820 Review.

6

Cost effectiveness of expanded antenatal HIV testing in London.

Postma MJ, Beck EJ, Hankins CA, Mandalia S, Jager JC, de Jong-van den Berg LT, Walters MD, Sherr L. Postma MJ, et al. AIDS. 2000 Oct 20;14(15):2383-9. doi: 10.1097/00002030-200010200-00020. AIDS. 2000. PMID: 11089627

7

[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].

Postma MJ, Bakker A, Welte R, van Bergen JE, van den Hoek JA, de Jong-van den Berg LT, Jager JC. Postma MJ, et al. Ned Tijdschr Geneeskd. 2000 Dec 2;144(49):2350-4. Ned Tijdschr Geneeskd. 2000. PMID: 11129971 Dutch.

8

Comparative model-based analysis of screening programs for Chlamydia trachomatis infections.

Kretzschmar M, Welte R, van den Hoek A, Postma MJ. Kretzschmar M, et al. Among authors: postma mj. Am J Epidemiol. 2001 Jan 1;153(1):90-101. doi: 10.1093/aje/153.1.90. Am J Epidemiol. 2001. PMID: 11159151

9

Socio-economic aspects of extended STD screening in pregnancy.

Postma MJ, Jager JC, de Jong-van den Berg LT. Postma MJ, et al. AIDS Care. 2000 Dec;12(6):731-5. doi: 10.1080/09540120020014273. AIDS Care. 2000. PMID: 11177452

10

Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands.

Postma MJ, Heijnen ML, Jager JC. Postma MJ, et al. Pharmacoeconomics. 2001;19(2):215-22. doi: 10.2165/00019053-200119020-00008. Pharmacoeconomics. 2001. PMID: 11284385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters